Mylan snaps up HIV-focused South African facility from Ascendis for $9.4M

9th January 2019 Uncategorised 0

Mylan shelled out $9.4 million for Ascendis Health’s South African manufacturing plant that is focused on producing antiretrovirals to combat HIV.

More: Mylan snaps up HIV-focused South African facility from Ascendis for .4M
Source: fierce